SANGAMO THERAPEUTICS, INC. (SGMOQ)

Import this data to Google Sheets with:

=jivedata("SGMOQ","financials")

Full statements spill as a table. For one cell: =jivedata("SGMOQ","Revenue") or =jivedata("SGMOQ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

SANGAMO THERAPEUTICS, INC.

SGMOQ • CIK 0001001233

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$176,232	$57,800	$39,552	$34,557
Operating Income (Loss)	$-274,005	$-103,969	$-121,239	$-123,557
Investment Income, Interest	—	—	$1,302	$1,302
Other Nonoperating Income (Expense)	—	—	$-3,563	$-1,753
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-262,903	$-98,108	$-123,500	$-124,017
Income Tax Expense (Benefit)	$-5,072	$-167	$-568	$-687
Net Income (Loss) Attributable to Parent	$-257,831	$-97,941	$-122,932	$-123,330
Weighted Average Number of Shares Outstanding, Basic	174,444,000	201,699,000	280,193,000	449,540,000
Research and Development Expense	$234,057	$111,521	$112,670	$113,234
General and Administrative Expense	$61,167	$44,727	$34,886	$31,645
Impairment of Long-Lived Assets Held-for-use	$65,528	$5,521	$13,235	$13,235
Operating Expenses	$450,237	$161,769	$160,791	$158,114

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$45,204	$41,918	$20,948	$27,586
Accounts Receivable, after Allowance for Credit Loss, Current	$923	$526	$371	$873
Property, Plant and Equipment, Net	$26,874	$17,887	$11,042	$10,317
Income Taxes Receivable, Current	—	$4,072	$10,142	$5,491
Operating Lease, Right-of-Use Asset	$25,991	$16,869	$3,064	$2,905
Prepaid Expense and Other Assets, Current	$12,000	$5,175	$4,369	$3,164
Income Taxes Receivable, Noncurrent	—	$12,809	$8,938	$8,759
Assets, Current	$94,328	$51,691	$35,830	$37,114
Other Assets, Noncurrent	$16,627	$879	$871	$870
Restricted Cash, Noncurrent	$1,500	$1,500	$0	$0
Assets	$165,320	$101,635	$59,745	$59,965
Contract with Customer, Liability, Noncurrent	$0	$5,874	$5,874	$5,874
Operating Lease, Liability, Noncurrent	$33,515	$26,253	$25,093	$19,332
Other Liabilities, Noncurrent	$1,187	$933	$580	$580
Liabilities	$82,433	$78,865	$74,013	$78,920
Accounts Payable, Current	$15,259	$15,485	$14,437	$19,307
Accrued Employee Benefits, Current	$8,918	$14,569	$17,721	$18,341
Accrued Liabilities, Current	$23,554	$8,195	$9,409	$15,084
Contract with Customer, Liability, Current	$0	$7,556	$899	$402
Liabilities, Current	$47,731	$45,805	$42,466	$53,134
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$1,781	$2,128	$3,507	$4,143
Additional Paid in Capital, Common Stock	$1,492,077	$1,532,489	$1,610,938	$1,637,659
Retained Earnings (Accumulated Deficit)	$-1,406,376	$-1,504,317	$-1,627,249	$-1,658,244
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-4,595	$-7,530	$-1,464	$-2,513
Stockholders' Equity Attributable to Parent	$82,887	$22,770	$-14,268	$-18,955
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	640,000,000	960,000,000	960,000,000	960,000,000
Common Stock, Shares, Issued	178,133,548	212,837,679	350,688,142	350,688,142
Property, Plant and Equipment, Gross	$77,920	$57,705	$53,253	$53,253
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$51,046	$39,818	$42,211	$42,211
Depreciation, Depletion and Amortization	$15,065	$5,107	$3,961	$719
Impairment of Long-Lived Assets Held-for-use	$65,528	$5,521	$13,235	$13,235
Operating Lease, Liability, Current	$4,589	$4,313	$1,702	$1,702
Accrued Professional Fees, Current	$1,505	$1,368	$817	$817
Restructuring Reserve, Current	$11,733	$896	$0	$0
Other Accrued Liabilities, Current	$1,964	$1,405	$1,133	$1,133

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-257,831	$-97,941	$-122,932	$-123,330
Net Cash Provided by (Used in) Operating Activities	$-224,842	$-67,139	$-97,208	$-90,341
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$1,483	$-2,048	$4,091	$2,048
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-55,240	$-3,286	$-22,470	$906
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$46,704	$43,418	$20,948	$21,854
Impairment of Long-Lived Assets Held-for-use	$65,528	$5,521	$13,235	$13,235
Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities	$214,500	$1,110	$0	$0
Depreciation, Depletion and Amortization	$15,065	$5,107	$3,961	$3,660
Proceeds from Sale of Debt Securities, Available-for-sale	—	$34,730	$0	$0
Operating Lease, Right-of-Use Asset, Amortization Expense	$7,127	$4,254	$3,641	$2,895
Proceeds from Sale of Productive Assets	—	—	$0	$0
Share-based Payment Arrangement, Noncash Expense	$27,363	$12,382	$9,079	$7,475
Payments to Acquire Property, Plant, and Equipment	$21,155	$267	$102	$115
Gain (Loss) on Disposition of Property Plant Equipment	—	$1,026	$0	$0
Net Cash Provided by (Used in) Investing Activities	$153,531	$37,524	$-102	$-115
Other Noncash Income (Expense)	$-1,119	$-330	$-32	$-42
Increase (Decrease) in Accounts Receivable	$-2,755	$-397	$-155	$507
Proceeds from Issuance of Private Placement	—	$21,859	$52,185	$55,917
Increase (Decrease) in Income Taxes Receivable	—	$-556	$0	$-4,525
Proceeds from Issuance of Common Stock	—	$7,132	$21,483	$34,468
Increase (Decrease) in Prepaid Expense and Other Assets	$-6,133	$-4,384	$-830	$-4,662
Payment, Tax Withholding, Share-based Payment Arrangement	$1,453	$904	$3,263	$1,415
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$5,589	$-14,169	$2,794	$3,514
Proceeds from Stock Plans	—	$290	$344	$344
Increase (Decrease) in Employee Related Liabilities	$-12,690	$5,743	$3,053	$4,274
Net Cash Provided by (Used in) Financing Activities	$14,588	$28,377	$70,749	$89,314
Increase (Decrease) in Contract with Customer, Liability	$-161,156	$13,430	$-6,657	$-7,154
IncreaseDecreaseInOperatingLeaseLiability	$-5,037	$-5,579	$-4,047	$-3,265
Increase (Decrease) in Other Noncurrent Liabilities	$-20	$-255	$-352	$-352
Capital Expenditures Incurred but Not yet Paid	$447	$236	$74	$-105

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("SGMOQ","financials")

Full statements spill as a table. For one cell: =jivedata("SGMOQ","Revenue") or =jivedata("SGMOQ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.